Clinical & translational oncology

• 

  Año 2026, Vol. 28, Número 10

  • REVIEW ARTICLE

    • Management of borderline resectable NSCLC: a narrative review

      Xabier Mielgo, Samantha Aso González, Eider Azkona Uribelarrea, Sergio Bolufer Nadal, Virginia Calvo de Juan, Margarita Martín Martín, Arturo Navarro Martín, R. Lopez Castro, Mariano Provencio Pulla, Juan Carlos Trujillo Reyes, Felipe Couñago Lorenzo

      • Resumen

      págs. 4277-4296

      

    • Interleukin-1α (IL-1α) in pancreatic ductal adenocarcinoma: implications for immunotherapy and molecular biomarkers

      Ke Ling, Guangfei Xie, Ze Chen, Mingxu Da, Zhisheng Qiu

      • Resumen

      págs. 4297-4307

      

    • Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction—a comprehensive review

      Nilambar Sethi, Chekuri Vinod Varma, Shiva Shankar Reddy

      • Resumen

      págs. 4308-4327

      

    • Mechanisms of chemoresistance in gastric cancer: interplay between microRNAs and the tumor microenvironment

      Vlad Costin Ilie, Corina Elena Minciuna, Catalin Andras, Simona Nicoleta Turcu, Vlad Herlea, Simona Olimpia Dima, Gabriela Droc, Monica Lacatus, Stefan Tudor, Catalin Vasilescu

      • Resumen

      págs. 4328-4345

      

    • The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications

      Shuzhen Wu, Luyao Yu, Meitong Liu, Bo Dong

      • Resumen

      págs. 4346-4358

      

    • Morphological and molecular characterization of epithelial ovarian cancer: SEOM-SEAP consensus guidelines for biomarker integration in clinical practice

      Gabriel Matheu Capó, María José Bermejo Pérez, Nuria Escudero García, Carmen García Durán, Sonia Gatius Calderó, Eva María Guerra Alía, Susana López Agullo, Ignacio Romero Noguera, Geanella Yange, Pilar Barretina Ginesta

      • Resumen

      págs. 4359-4375

      

    • Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications

      Patricia Willisch Santamaría, Beatriz Vazquez Barreiro, Ana Plata Bello, Irene Cienfuegos Belmonte, Gloria Guardia, Rocío del Castillo Acuña, Giulio Francolini, Ciro Franzese, José Daniel Subiela Henríquez, Felipe Couñago Lorenzo, F. López Campos

      • Resumen

      págs. 4376-4388

      

    • Head and neck squamous cell carcinoma: current and emerging therapeutic strategies

      Parul Ahuja, Lokesh Kadian, Sandeep Goyal, Ritu Yadav

      • Resumen

      págs. 4389-4418

      

    • Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review

      JiaJu Xu, ChunXiao Ni, Lidong Qin, Ping Wang, JiaJu Xu

      • Resumen

      págs. 4419-4460

      

    • Evidence-steered medicine in oncology: network-aware micro-combinations that safeguard standard of care and potentially improve benefit–risk

      Konstantin Gurbanov

      • Resumen

      págs. 4461-4468

      

    • Liquid biopsy in modern medicine: advancing diagnostics from molecular insights to clinical practice

      Vivek Kumar Dhiman, Stuti Srivastava, Manju Kumari, Devendra Singh

      • Resumen

      págs. 4469-4490

      

    • Ferroptosis in cancer: molecular mechanisms, biological roles, and therapeutic significance

      Honghua Huang, Jintong Na, Jijie Shao, Qun Yang, Jingyi Su, Yupei Xu, Yongxiang Zhao, Liping Zhong

      • Resumen

      págs. 4491-4510

      

    • Recent advances in the regulation of CD47 by non-coding RNAs and its therapeutic potential in cancer

      Jingwen Hua, Weijin Zhu, Xiaochun Sun, Huabiao Chen

      • Resumen

      págs. 4511-4532

      

    • Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors

      Ignacio Pérez Criado, Mariona Fígols, Ainhoa Moya Sevilla, Ana Bautista, Daniela Gómez Díaz, Albert Font, Juan Martin Liberal, Vicenç Ruiz de Porras

      • Resumen

      págs. 4533-4545

      

    • Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy

      Sonia Pernas Simon, Xavier Forns Bernhardt, Olga Martínez Sáez, Raúl Andrade, Alberto Amador, Elena López Miranda, Begoña Bermejo, Beatriz Mateos, Mónica Cejuela, María José Villanueva, Patricia Palacios Ozores, Mar Riveiro Barciela, Meritxel Bellet Ezquerra

      • Resumen

      págs. 4546-4559

      

    • Long noncoding RNAs in female malignancies: critical review of molecular mechanisms, clinical gaps, and therapeutic perspectives

      Xia Liu, Xia Li, Shaofeng Zou, Li Hao, Xiuyang Xie

      • Resumen

      págs. 4560-4574

      

    • CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

      Elena A. Nemilostiva, Olga A. Paevskaya, Shuxrat Boymuradov, Baqodir Safoyev, Mirmukhsin Satov

      • Resumen

      págs. 4575-4596

      

    • Role of the MDM2/p53 axis in regulating cisplatin response in tumor cells

      Yasamin Rajabloo, Iman Akhlaghipour, Negin Taghehchian, Meysam Moghbeli

      • Resumen

      págs. 4597-4609

      

  • RESEARCH ARTICLE

    • A novel nomogram incorporating LASSO and Cox regression analyses for predicting survival in early-stage non-small cell lung cancer patients following sublobectomy

      Shuquan Wang, Yunqing Chen, Xiaolin Ma, Zhaojun Yin

      • Resumen

      págs. 4610-4619

      

    • SSX1 and TRIM58 expression stratifies lung squamous cell carcinoma by tumor immune microenvironment characteristics and informs potential immunotherapy responsiveness

      Xiaoling Zhao, Chengyu Liu, Jiawen Sun, Chengcheng Wang, Qi Shen, Xiaochong Zhang, Dandan Liu, Jing Xie, Xu Yang, Dengxiang Liu

      • Resumen

      págs. 4620-4632

      

    • Impact of lung cancer diagnosis on patient lifestyle and physical activity

      Alejandro Jiménez Marín, Sara Cerezo González, Patricia Cruz Castellanos, Lourdes Fernández Franco, Natalia Rioja Collado, Virginia García Coll, Mónica Castellanos Montealegre

      • Resumen

      págs. 4633-4642

      

    • Association between the systemic inflammation response index and prognosis in lung cancer: a systematic review and meta-analysis

      Tongtong Chu, Xiuxi Li, Lijuan Shan, Chunshan Zhao

      • Resumen

      págs. 4643-4656

      

    • Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis

      Aryane Cristina de Figueiredo Azevedo, Raissa Martins da Silva, Felipe Alves de Paiva, Luis Henrique Rios Moreira Rego, Francisco Cezar Aquino de Moraes

      • Resumen

      págs. 4657-4665

      

    • Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery: defining a unique acute immune landscape

      Yastira Ramdas, Catherine Worsley, Pieter Willem Meyer, Carol Ann Benn

      • Resumen

      págs. 4666-4682

      

    • Receptor status, molecular subtypes, and survival outcomes of breast cancer following gastric cancer compared with single primary breast cancer

      Ahmet Necati Sanli, Bilal Turan, Deniz Esin Tekcan Sanli, Isa Karaca, Fatih Aydogan

      • Resumen

      págs. 4683-4694

      

    • Ovarian tissue cryopreservation in girls and adolescents at risk of gonadotoxicity: a 15-year experience in 159 patients from a referral program

      Mara Andrés Moreno, Javier Gómez Chacón, Patricia Torres Gómez, Pedro José Fernández Colom, Jorge Cortés Sáez, Alfredo Marco Macián, Helena Martínez Sánchez, Bárbara Torres Guerola, María Teresa Tormo Alcañiz, Pilar Morillas Amat, Patrocinio Polo Sánchez, José María Rubio Rubio, Edurne Novella Maestre, Vicente Mirabet, María Adela Cañete Nieto, Francisca Moreno Macián

      • Resumen

      págs. 4695-4705

      

    • Textbook outcome in ovarian cancer with peritoneal carcinomatosis: a systematic review

      Silvia Carbonell Morote, Pedro Antonio Cascales Campos, Álvaro Arjona Sánchez, Juan Jesús Rubio García, Celia Villodre Tudela, Francisco Javier Lacueva Gómez, José Manuel Ramia Ángel

      • Resumen

      págs. 4706-4713

      

    • Tozasertib + cisplatin inhibits proliferation, migration, and induces apoptosis in esophageal carcinoma cells

      Chunqin Tian, Lichun Cui, Xiaoyan Wang

      • Resumen

      págs. 4714-4727

      

    • Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain

      P. Jiménez Fonseca, Marc Díez Garcia, Juan Luis Catoya Villa, Pablo Perez Wert, Laura Visa, Alberto Carmona Bayonas, María Luisa Limón Mirón, Ana Fernández Montes, Margarita Reboredo López, María del Rosario Vidal Tocino, Javier Gallego Plazas, Guillermo Eduardo Mendoza, Stefania Landolfi, Ana Teijo Quintáns, Laura Guerra Pastrián, Andrés Nieto, José Luis Domínguez Miranda, María Luisa López Vega, Marta Rodríguez González, Francisco José Illán Gambín, Eva Martínez de Castro, Cinta Hierro Carbó, Mireia Gil Raga, María Robles González, Mar Iglesias Coma

      • Resumen

      págs. 4728-4737

      

  • REVIEW ARTICLE

    • HER2 discordance between primary and metastatic gastric cancer: a systematic review and meta-analysis

      Francisco Cezar Aquino de Moraes, Luis Henrique Rios Moreira Rego, Thiago Gorayeb Rebelo, Gustavo Tadeu Freitas Uchôa Matheus, Ana C. Melo

      • Resumen

      págs. 4738-4748